Source comparison
PT-141 vs Viagra Cialis Mechanism Comparison
Primary Mechanism Melanocortin receptor (MC3R/MC4R) agonist in hypothalamus PDE5 inhibitor in vascular smooth muscle PT-141 initiates arousal centrally; PDE5 inhibitors amplify peripheral vascular response Site of Action Central nervous system (hypothalamic nu
This comparison does not assign a generated winner or score.
- Primary Mechanism
- Melanocortin receptor (MC3R/MC4R) agonist in hypothalamus
- PDE5 inhibitor in vascular smooth muscle
- PT-141 initiates arousal centrally; PDE5 inhibitors amplify peripheral vascular response
- Site of Action
- Central nervous system (hypothalamic nuclei)
- Peripheral (penile arteries, corpus cavernosum)
- Fundamentally different pathways. One affects desire, the other affects blood flow
- Requires Sexual Stimulation
- No. Generates arousal signaling independently
- Yes. Amplifies NO released during stimulation
- PT-141 works without external stimulus; PDE5 inhibitors require existing arousal
- Route of Administration
- Subcutaneous injection (autoinjector pen)
- Oral tablet
- Injection route bypasses first-pass metabolism but adds administration complexity
- Onset of Action
- 30–45 minutes
- 30–60 minutes
- 1–2 hours
- All require advance planning; tadalafil slowest but longest duration
- Duration of Effect
- 8–12 hours
- 4–6 hours
- 24–36 hours
- Tadalafil's extended window allows spontaneity; bremelanotide duration tied to receptor occupancy
- Efficacy in Women
- FDA-approved for HSDD in premenopausal women
- No efficacy in female sexual dysfunction
- Only PT-141 addresses central arousal deficits; PDE5 inhibitors don't treat desire pathology
- Efficacy in Vascular ED
- Limited. Improves arousal but not blood flow capacity
- High. First-line treatment for vascular ED
- PDE5 inhibitors are standard of care for vascular pathology; PT-141 doesn't address endothelial dysfunction
- Common Side Effects
- Nausea (40%), flushing (20%), injection site reactions
- Headache (16%), flushing (10%), dyspepsia (7%)
- Headache (11%), dyspepsia (10%), back pain (6%)
- PT-141's nausea is dose-limiting in some patients; PDE5 side effects reflect vasodilation
- Contraindications
- Uncontrolled hypertension, cardiovascular disease
- Nitrate use (risk of severe hypotension)
- PT-141 raises blood pressure transiently; PDE5 inhibitors contraindicated with nitroglycerin